GILEAD SCIENCES, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
GILEAD SCIENCES, INC. (GILD) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $11.74 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $11.74B.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $23.43B.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $22.62B.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $21.46B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $11.74B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $23.43B 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $22.62B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $21.46B 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $19.59B 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $19.08B 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $19.25B 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $18.39B 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $18.20B 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $17.45B 10-Q · filed 2025-08-07 | |
| 2023-12-31 | $22.75B 10-K · filed 2026-02-24 | |
| 2023-09-30 | $22.24B 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $21.09B 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $20.94B 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $21.21B 10-K · filed 2026-02-24 | |
| 2022-09-30 | $21.06B 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $20.21B 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $19.91B 10-Q · filed 2023-08-04 | |
| 2021-12-31 | $21.06B 10-K · filed 2025-02-28 | |
| 2021-09-30 | $21.47B 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $19.71B 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $18.96B 10-Q · filed 2022-08-08 | |
| 2020-12-31 | $18.22B 10-K · filed 2024-02-23 | |
| 2020-09-30 | $17.47B 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $18.14B 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $22.18B 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $22.65B 10-K · filed 2023-02-22 | |
| 2019-09-30 | $20.74B 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $22.75B 10-Q · filed 2020-11-04 | |
| 2019-03-31 | $22.09B 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $21.53B 10-K · filed 2022-02-23 | |
| 2018-09-30 | $23.01B 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $21.73B 10-Q · filed 2019-11-05 | |
| 2018-03-31 | $20.65B 10-Q · filed 2019-08-06 | |
| 2017-12-31 | $20.50B 10-K · filed 2021-02-25 | |
| 2017-09-30 | $25.25B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $23.09B 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $20.92B 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $19.36B 10-K · filed 2020-02-25 | |
| 2016-09-30 | $17.36B 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $16.11B 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $14.02B 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $19.11B 10-K · filed 2019-02-26 | |
| 2015-09-30 | $17.94B 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $16.63B 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $17.59B 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $15.82B 10-K · filed 2018-02-27 | |
| 2014-09-30 | $13.86B 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $16.43B 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $13.70B 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $11.74B 10-K · filed 2017-02-27 | $11.74B 10-K · filed 2014-02-25 |
| 2013-09-30 | $11.19B 10-Q · filed 2013-10-31 | |
| 2013-06-30 | $11.34B 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $10.39B 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $9.54B 10-K · filed 2016-02-24 | $9.55B 10-K · filed 2013-02-27 |
| 2012-09-30 | $8.75B 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $8.08B 10-Q · filed 2012-08-01 | |
| 2012-03-31 | $7.36B 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $6.87B 10-K · filed 2015-02-25 | $6.87B 10-K · filed 2012-02-23 |
| 2011-09-30 | $6.23B 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $6.21B 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $6.18B 10-Q · filed 2011-05-09 | |
| 2010-12-31 | $6.12B 10-K · filed 2014-02-25 | |
| 2010-09-30 | $5.88B 10-Q · filed 2010-11-08 | |
| 2010-06-30 | $6.70B 10-Q · filed 2010-08-09 | |
| 2010-03-31 | $7.50B 10-Q · filed 2010-05-10 | |
| 2009-12-31 | $6.51B 10-K · filed 2013-02-27 | |
| 2009-09-30 | $5.75B 10-Q · filed 2009-11-05 | |
| 2009-06-30 | $5.31B 10-Q · filed 2009-08-05 | |
| 2008-12-31 | $4.47B 10-K · filed 2012-02-23 | |
| 2007-12-31 | $3.75B 10-K · filed 2011-02-28 | |
| 2006-12-31 | $2.05B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |